Synonym
NAV-2729; NAV 2729; NAV2729; Grassofermata;
IUPAC/Chemical Name
3-(4-Chlorophenyl)-5-(4-nitrophenyl)-2-(phenylmethyl)pyrazolo[1,5-a]pyrimidin-7(4H)-one
InChi Key
GUUWHOSUKOCRHG-UHFFFAOYSA-N
InChi Code
InChI=1S/C25H17ClN4O3/c26-19-10-6-18(7-11-19)24-22(14-16-4-2-1-3-5-16)28-29-23(31)15-21(27-25(24)29)17-8-12-20(13-9-17)30(32)33/h1-13,15,27H,14H2
SMILES Code
O=C1C=C(C2=CC=C([N+]([O-])=O)C=C2)NC3=C(C4=CC=C(Cl)C=C4)C(CC5=CC=CC=C5)=NN13
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Biological target:
NAV-2729 is a dual Arf1/Arf6 activation inhibitor.
In vitro activity:
Grassofermata was effective in inhibiting the uptake of FA analog C1-BODIPY-C12 in C2C12 and INS-1E cells with IC50 of 10.6 and 8.3 μM respectively (Fig. 1C and 1D). By comparison, the IC50 was higher in human adipocytes (58.2 μM; Fig. 1E). As expected, Grassofermata exhibited a non-competitive mechanism of inhibition (Fig. 1F).
Reference: Biochem Biophys Res Commun. 2015 Sep 25;465(3):534-41. https://pubmed.ncbi.nlm.nih.gov/26284975/
|
Solvent |
mg/mL |
mM |
Solubility |
DMSO |
47.2 |
103.25 |
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
456.89
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
Formulation protocol:
1. Black PN, Ahowesso C, Montefusco D, Saini N, DiRusso CC. Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids. Medchemcomm. 2016 Apr 1;7(4):612-622. doi: 10.1039/C6MD00043F. Epub 2016 Feb 19. PMID: 27446528; PMCID: PMC4948302.
2. Saini N, Black PN, Montefusco D, DiRusso CC. Fatty acid transport protein-2 inhibitor Grassofermata/CB5 protects cells against lipid accumulation and toxicity. Biochem Biophys Res Commun. 2015 Sep 25;465(3):534-41. doi: 10.1016/j.bbrc.2015.08.055. Epub 2015 Aug 15. PMID: 26284975; PMCID: PMC4589248.
In vitro protocol:
1. Black PN, Ahowesso C, Montefusco D, Saini N, DiRusso CC. Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids. Medchemcomm. 2016 Apr 1;7(4):612-622. doi: 10.1039/C6MD00043F. Epub 2016 Feb 19. PMID: 27446528; PMCID: PMC4948302.
2. Saini N, Black PN, Montefusco D, DiRusso CC. Fatty acid transport protein-2 inhibitor Grassofermata/CB5 protects cells against lipid accumulation and toxicity. Biochem Biophys Res Commun. 2015 Sep 25;465(3):534-41. doi: 10.1016/j.bbrc.2015.08.055. Epub 2015 Aug 15. PMID: 26284975; PMCID: PMC4589248.
1: Yoo JH, Shi DS, Grossmann AH, Sorensen LK, Tong Z, Mleynek TM, Rogers A, Zhu
W, Richards JR, Winter JM, Zhu J, Dunn C, Bajji A, Shenderovich M, Mueller AL,
Woodman SE, Harbour JW, Thomas KR, Odelberg SJ, Ostanin K, Li DY. ARF6 Is an
Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma.
Cancer Cell. 2016 Jun 13;29(6):889-904. doi: 10.1016/j.ccell.2016.04.015. PubMed
PMID: 27265506; PubMed Central PMCID: PMC5027844.